Buscar
Mostrando ítems 1-10 de 842
Transforming vaccine development
The urgency to develop vaccines against Covid-19 is putting pressure on the long and expensive development
timelines that are normally required for development of lifesaving vaccines. There is a unique opportunity to ...
Surveillance for adverse events after DTwP/Hib vaccination in Brazil: Sensitivity and factors associated with reporting
(ELSEVIER SCI LTD, 2010)
We estimated the sensitivity, i.e., the proportion of all cases of adverse events following immunization (AEFIs) reported to the Brazilian passive surveillance for adverse events following immunization (PSAEFI) with the ...
New vaccines needed for pathogens infecting animals and humans: One Health
(Taylor and Francis, 2012)
The field of "One Health" encourages researchers to collaborate across a wide range of disciplines to improve health at the animal-human- ecosystems interface. One Health recognizes the potential of emerging infectious ...
Surveillance for adverse events after DTwP/Hib vaccination in Brazil: sensitivity and factors associated with reporting
(Kidlington, 2010)
We estimated the sensitivity, i.e., the proportion of all cases of adverse events following immunization (AEFIs) reported to the Brazilian passive surveillance for adverse events following immunization (PSAEFI) with the ...
Safety of a nasal vaccine against Streptococcus pneumoniae using heat-killed Lactobacillus casei as adjuvant
(Elsevier Gmbh, 2014-01)
Streptococcus pneumoniae is a highly important respiratory pathogen that causes infections in children, elderly people and immunocompromised people around the world. Pneumococcal vaccines licensed did not reach to eradicate ...
Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety
A degraded/dysfunctional immune system appears to be the main determinant of
serious/fatal reaction to viral infection (for COVID-19, SARS, and influenza alike). There are
four major approaches being employed or considered ...
Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease
(Expert Reviews, 2014)
Chagas disease is a neglected tropical disease caused by the protozoan parasite Trypanosoma
cruzi. This illness is now becoming global, mainly due to congenital transmission, and so far,
there are no prophylactic or ...
Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines
Several live-attenuated viral vaccine candidates are among the COVID-19 vaccines in development. The
Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe ...